WNT10B and acute myeloid leukemia: Subsequently, using a cohort of healthy donors, favorable AML responders, and intermediate/unfavorable responders, WNT10B was shown to be expressed in only AML patients and not in healthy donors (Lazzaroni et al., 2016).